MedPath

Pilot Study of Vedic Medicine for Type 2 Diabetes

Phase 2
Completed
Conditions
Diabetes Mellitus, Type 2
Registration Number
NCT00065650
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Brief Summary

The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.

Detailed Description

Maharishi Vedic Medicine (MVM) represents a synthesis of Vedic sciences, including Ayur-Veda, into a single, comprehensive, natural approach to health care. The objectives of this phase II pilot trial are to determine the feasibility, acceptability, and safety of implementing a multi-modality MVM intervention for newly diagnosed type 2 diabetics, and to measure the impact of such a protocol on overall glycemic control.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
HbA1C3 months
Secondary Outcome Measures
NameTimeMethod
Lipids3 and 6 months
Fasting Glucose3 and 6 months

Trial Locations

Locations (1)

Kaiser Permanente Center for Health Research

πŸ‡ΊπŸ‡Έ

Portland, Oregon, United States

Kaiser Permanente Center for Health Research
πŸ‡ΊπŸ‡ΈPortland, Oregon, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.